Pharma stocks rebounded and rose into the green Monday afternoon after details of President Donald Trump’s executive order on drug prices became public.
Category: research and development in the united states
Auto Added by WPeMatico
-
Eli Lilly stock sinks as pharma misses out on the market rally
Pharma companies were mostly left out of the stock market’s broader rally Monday morning on the news that President Donald Trump will sign an order lowering drug prices.
-
GM, UPS, Coca-Cola, Spotify: Stocks to watch today
U.S. futures were mixed early Tuesday as markets braced for a high-stakes earnings deluge. Dow futures rose 0.3%, while the S&P and Nasdaq ticked down slightly.
-
Eli Lilly promises to make new weight-loss pill in the U.S.
Eli Lilly (LLY) CEO Dave Ricks said Friday that the company will make its planned GLP-1 weight-loss pill in the U.S. amid President Donald Trump’s sweeping tariffs and his push to get companies to move production inside the country’s borders.
-
Pfizer just had a big setback in its race for an Ozempic competitor
Pfizer (PFE) announced Monday that it is ending development of its daily weight-loss pill following a liver injury to a patient participating in a trial.